NDBK.Y, the OTC-traded American depositary receipt for South African lender Nedbank Group, closed Wednesday at $15.73 — down nearly 3% on the week — as short positions rebuilt sharply and borrowing costs continued a weeks-long retreat from their highs.
The most striking development in the data this week is the pace at which short positions have accumulated. Estimated short shares jumped more than 227% over the past seven sessions, rising from around 8,700 to nearly 28,600. Zooming out to a month, the increase is even steeper — up more than 315% from early April levels. On their own, those numbers look dramatic. But context matters: this is a thinly traded OTC receipt, and the raw share counts are small enough that the percentage moves can be exaggerated by a handful of transactions. What is clear is that some participants have added meaningful directional short exposure ahead of Nedbank's next scheduled results, flagged for May 29.
The borrow picture tells a more nuanced story. Cost to borrow has fallen sharply — dropping roughly 38% over the past week to 8.1%, and more than 55% below its month-ago level of around 18%. That means the borrow market has loosened considerably even as positions grow, which is the opposite of a squeeze dynamic. Availability has eased alongside: the lending pool is far from stressed. The 52-week high utilization reading of nearly 96% — seen in early April, when borrow also peaked — now looks like a distant episode. Current utilization is running at just 3.6%, indicating wide availability for anyone who wants to establish or expand a short. The short score itself reflects this mixed picture: it ticked up to 31.2 this week but remains well below its April 23 spike of 49.6, suggesting the market's short-side conviction is rebuilding but not yet elevated.
Nedbank's earnings history provides the sharpest context for that approaching May date. The last four reporting events on record all resulted in negative price reactions — a consistent pattern. The March 2026 print saw a one-day drop of around 5%, followed by a five-day decline close to 13%. A release in early March produced a similar 5% one-day fall. The most severe in the recent set was a single-day decline of just under 9%, with a five-day follow-through of nearly 13%. That is a notably consistent downside reaction profile across recent results, which likely informs at least some of the current short rebuild.
On the factor side, the stock scores a near-perfect 98th percentile on the dividend score — a reminder that this is fundamentally a yield-driven holding for many international investors. Forward EPS growth expectations are also relatively solid, ranking in the 79th percentile on the 12-month forward YoY increase measure. Where the setup looks weaker is on near-term earnings momentum, with 30-day and 90-day EPS momentum both sitting around the 30th percentile. Valuation data for the OTC receipt is stale and unreliable given the ADR structure and ZAR-denominated underlying, so no multiple estimates are included here.
The institutional register underscores the South African ownership character of the name. The Public Investment Corporation holds close to 17%, with Allan Gray at 8.5% and a cluster of domestic South African asset managers — Coronation, Old Mutual, Ninety One, Sanlam — each holding between 3.5% and 5.5%. Western names including BlackRock, Vanguard, and Norges Bank are present but represent a smaller slice. Norges Bank trimmed its position by roughly 1.4 million shares in its last disclosed filing, a move worth watching for continuation.
With the May 29 results window now firmly in view, the question for Nedbank's OTC receipt is whether the short rebuild — modest in absolute terms but accelerating — reflects a genuine bearish view on the upcoming print, or simply routine repositioning in a thin market with a consistent history of post-earnings weakness.
See the live data behind this article on ORTEX.
Open NDBK.Y on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
